Thermo Fisher, Principal Financial Group, And Two Promising ETFs Steal The Show On CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named SPDR S&P Biotech ETF XBI, which is trading in a tight range between $75 and $90.

Josh Brown of Ritholtz Wealth Management said iShares U.S. Aerospace & Defense ETF ITA, is a couple of dollars away from breaking its pre-COVID high.

Don’t forget to check out our premarket coverage here

Jim Lebenthal of Cerity Partners said Thermo Fisher Scientific Inc. TMO is a "high-quality company" in the healthcare space.

Thermo Fisher Scientific is scheduled to host Investor Day on May 24 at 9:00 a.m. ET.

Benzinga's analyst ratings data finds a consensus Buy rating on TMO. 

Rob Sechan of New Edge Capital Group picked Principal Financial Group, Inc. PFG, saying that it is a "cheap way" to play financials.

Principal Financial is expected to release Q1 financial results after the closing bell on April 27, 2023.

Price Action: Thermo Fisher Scientific shares rose 2% to close at $591.13, while Principal Financial fell 0.4% to settle at $75.07 on Thursday. The SPDR S&P Biotech ETF gained 4.4% to $79.43, while iShares U.S. Aerospace & Defense ETF rose 0.5% to $116.89 on Thursday.

Check This Out: Over $1M Bet On This Real Estate Stock? Check Out These 3 Stocks Insiders Are Buying